IL18 and hepatocellular carcinoma: On the other hand, NLRP3 inflammasome activation can lead to excessive production of inflammatory cytokines such as IL-1β and IL-18, significantly affecting the tumor microenvironment and potentially promoting HCC growth (14, 25, 33).